Literature DB >> 23744885

Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients.

Anne C Beaubrun1, Ryan D Kilpatrick, Janet K Freburger, Brian D Bradbury, Lily Wang, M Alan Brookhart.   

Abstract

Patients with ESRD have a substantially increased risk of bone fractures, but the burden of fractures has not been sufficiently characterized in this population. Here, we analyzed fracture rates and postdischarge outcomes using Medicare data from hemodialysis patients in the United States between 2000 and 2009. We assessed adjusted quarterly fracture rates (inpatient and outpatient) and consequences of postfracture hospitalization for seven categories of fracture location. Pelvis/hip, vertebral, and lower leg fractures were the most prevalent fracture types. Pelvis/hip fractures declined slightly from 29.6 to 20.6 per 1000 patient-years between early 2000 and late 2009, but the incidence rates for all other fracture types remained relatively constant. Median lengths of stay for the primary fracture hospitalization ranged from 5 days (interquartile range [IQR], 3-9 days) for forearm/wrist fractures to 8 days (IQR, 5-12 days) for femur fractures. The proportion of patients discharged from the primary hospitalization to a skilled-nursing facility ranged from 28% (ribs/sternum) to 47% (pelvis/hip). A negative binomial regression model suggested that patients had an adjusted mean of 3.8-5.2 additional hospitalizations during the year after discharge from the index hospitalization, varying by fracture type, comprising a mean of 33-52 inpatient days. Case-mix-adjusted mortality rates after discharge ranged from 0.43 to 0.91 per patient-year and were highest for vertebral, pelvis/hip, and femur fractures. In conclusion, fractures in the dialysis population are common and are associated with a substantially increased risk for death and hospitalization.

Entities:  

Mesh:

Year:  2013        PMID: 23744885      PMCID: PMC3752946          DOI: 10.1681/ASN.2012090916

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  40 in total

Review 1.  Bisphosphonates in the renal patient.

Authors:  John Cunningham
Journal:  Nephrol Dial Transplant       Date:  2007-06       Impact factor: 5.992

2.  Trends in hospital care for hip fractures.

Authors:  S H Gehlbach; J S Avrunin; E Puleo
Journal:  Osteoporos Int       Date:  2006-12-05       Impact factor: 4.507

Review 3.  Vitamin D deficiency and secondary hyperparathyroidism among patients with chronic kidney disease.

Authors:  Samina Khan
Journal:  Am J Med Sci       Date:  2007-04       Impact factor: 2.378

Review 4.  Racial and survival paradoxes in chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Stephen F Derose; Tamara B Horwich; Gregg C Fonarow
Journal:  Nat Clin Pract Nephrol       Date:  2007-09

5.  Trends in hip fracture rates in Canada.

Authors:  William D Leslie; Siobhan O'Donnell; Sonia Jean; Claudia Lagacé; Peter Walsh; Christina Bancej; Suzanne Morin; David A Hanley; Alexandra Papaioannou
Journal:  JAMA       Date:  2009-08-26       Impact factor: 56.272

6.  Incidence and mortality of hip fractures in the United States.

Authors:  Carmen A Brauer; Marcelo Coca-Perraillon; David M Cutler; Allison B Rosen
Journal:  JAMA       Date:  2009-10-14       Impact factor: 56.272

7.  Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006.

Authors:  Wendy L St Peter; Qi Li; Jiannong Liu; Martha Persky; Kimberly Nieman; Cheryl Arko; Geoffrey A Block
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-07       Impact factor: 8.237

8.  The association of race, gender, and comorbidity with mortality and function after hip fracture.

Authors:  Joan D Penrod; Ann Litke; William G Hawkes; Jay Magaziner; John T Doucette; Kenneth J Koval; Stacey B Silberzweig; Kenneth A Egol; Albert L Siu
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-08       Impact factor: 6.053

9.  Racial differences in mortality and ESRD.

Authors:  Keith Norris; Rajnish Mehrotra; Allen R Nissenson
Journal:  Am J Kidney Dis       Date:  2008-08       Impact factor: 8.860

Review 10.  Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.

Authors:  Melanie S Joy; Paul C Karagiannis; Fred W Peyerl
Journal:  J Manag Care Pharm       Date:  2007-06
View more
  45 in total

1.  A Systematic Review and Meta-analysis of the Association Between Vitamin K Antagonist Use and Fracture.

Authors:  Wendy Fiordellisi; Katherine White; Marin Schweizer
Journal:  J Gen Intern Med       Date:  2018-12-03       Impact factor: 5.128

2.  Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis.

Authors:  A-J Chang; Q Ying; X-N Chen; W-M Wang; N Chen
Journal:  Osteoporos Int       Date:  2016-07-08       Impact factor: 4.507

3.  Declining Rates of Hip Fracture in End-Stage Renal Disease: Analysis From the 2003-2011 Nationwide Inpatient Sample.

Authors:  Sun Moon Kim; Sai Liu; Jin Long; Maria E Montez-Rath; Mary B Leonard; Glenn M Chertow
Journal:  J Bone Miner Res       Date:  2017-09-11       Impact factor: 6.741

4.  Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.

Authors:  Anne M Butler; Andrew F Olshan; Abhijit V Kshirsagar; Jessie K Edwards; Matthew E Nielsen; Stephanie B Wheeler; M Alan Brookhart
Journal:  Am J Kidney Dis       Date:  2015-02-07       Impact factor: 8.860

5.  Fractures in Patients with CKD: Time for Action.

Authors:  Sharon M Moe; Thomas L Nickolas
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 8.237

6.  Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis.

Authors:  Chandan Vangala; Jingbo Niu; Colin R Lenihan; William E Mitch; Sankar D Navaneethan; Wolfgang C Winkelmayer
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-27       Impact factor: 8.237

7.  The Likelihood of Self-reporting Balance Problems in Those With Advanced Chronic Kidney Disease, Slow Gait Speed, or Low Vitamin D.

Authors:  Jordan F Wickstrom; Harlan R Sayles; Laura A Graeff-Armas; Jennifer M Yentes
Journal:  J Ren Nutr       Date:  2018-12-21       Impact factor: 3.655

8.  Bone fracture risk factors in prevalent hemodialysis patients.

Authors:  Patrícia João Matias; Ivo Laranjinha; Ana Azevedo; Ana Raimundo; David Navarro; Cristina Jorge; Inês Aires; Marco Mendes; Carina Ferreira; Tiago Amaral; Célia Gil; Aníbal Ferreira
Journal:  J Bone Miner Metab       Date:  2019-09-05       Impact factor: 2.626

9.  Hip hemiarthroplasty for femoral neck fractures in end-stage renal disease patients on dialysis compared to patients with late-stage chronic kidney disease.

Authors:  Benjamin Tk Ding; Abhishek Shinde; Kelvin G Tan
Journal:  Singapore Med J       Date:  2019-08       Impact factor: 1.858

Review 10.  The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease.

Authors:  Martin Jannot; Fabrice Mac-Way; Vanessa Lapierre; Marie-Helene Lafage-Proust
Journal:  J Nephrol       Date:  2017-09-12       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.